CLINICAL_TRIALS trial_result · 2022-10-24

Clinical Trial Update: Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis [Phase 4]

Phase 4 trial analyzing cytokine response to 0.3mg Lucentis in diabetic macular edema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vitreo-Retinal Associates, Michigan | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2022-10-24